Related references
Note: Only part of the references are listed.Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis
Nadira Ruzehaji et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes
Kelvin Yin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Animal models of scleroderma: recent progress
Roberta G. Marangoni et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
A PPARδ-selective antagonist ameliorates IMQ-induced psoriasis-like inflammation in mice
Xuguo Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Nguan Soon Tan et al.
PROGRESS IN LIPID RESEARCH (2016)
Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics
Jennifer L. Sargent et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Systemic Sclerosis Commonly Asked Questions by Rheumatologists
Amber Young et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2015)
Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
Xiaoling Wang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Evaluation of the Efficacy and Safety of Topical Imiquimod 5% for Plaque-Type Morphea: A Multicenter, Prospective, Vehicle-Controlled Trial
Marlene Dytoc et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2015)
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Kristina E. N. Clark et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Increased Expression of NAPDH Oxidase 4 in Systemic Sclerosis Dermal Fibroblasts Regulation by Transforming Growth Factor β
Sonsoles Piera-Velazquez et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A Reactive Oxygen Species-Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis
Tatiana Spadoni et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Gastrointestinal manifestations of systemic disease: a multimodality review
John Nay et al.
ABDOMINAL IMAGING (2015)
Role of Cellular Senescence and NOX4-Mediated Oxidative Stress in Systemic Sclerosis Pathogenesis
Sonsoles Piera-Velazquez et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Angiopoietin-like 4 Stimulates STAT3-mediated iNOS Expression and Enhances Angiogenesis to Accelerate Wound Healing in Diabetic Mice
Han Chung Chong et al.
MOLECULAR THERAPY (2014)
IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts
M. I. Suwara et al.
MUCOSAL IMMUNOLOGY (2014)
United Kingdom survey of current management of juvenile localized scleroderma
Daniel P. Hawley et al.
RHEUMATOLOGY (2014)
Fibroblasts in fibrosis: novel roles and mediators
Ryan T. Kendall et al.
FRONTIERS IN PHARMACOLOGY (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
The myofibroblast matrix: implications for tissue repair and fibrosis
Franco Klingberg et al.
JOURNAL OF PATHOLOGY (2013)
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
Xiaomeng Wang et al.
NATURE (2013)
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Adrian J. Gilbane et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Nuclear Receptors and Their Selective Pharmacologic Modulators
Thomas P. Burris et al.
PHARMACOLOGICAL REVIEWS (2013)
Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets
Matthew B. Greenblatt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice
Jose Iglesias et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Skin-Targeted Inhibition of PPAR β/δ by Selective Antagonists to Treat PPAR β/δ - Mediated Psoriasis-Like Skin Disease In Vivo
Katrin Hack et al.
PLOS ONE (2012)
Loss of PPAR gamma expression by fibroblasts enhances dermal wound closure
Wei Sha et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Liver autoantibodies in patients with scleroderma
Thelma L. Skare et al.
CLINICAL RHEUMATOLOGY (2011)
Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver
Christoph H. Oesterreicher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nuclear receptors as drug targets for metabolic disease
Ira G. Schulman
ADVANCED DRUG DELIVERY REVIEWS (2010)
Animal models of scleroderma: fresh insights
Carol M. Artlett
CURRENT OPINION IN RHEUMATOLOGY (2010)
Epithelial Cells Promote Fibroblast Activation via IL-1α in Systemic Sclerosis
Nima Aden et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Activation of PPARβ/δ Causes a Psoriasis-Like Skin Disease In Vivo
Malgorzata Romanowska et al.
PLOS ONE (2010)
Loss of Peroxisome Proliferator-Activated Receptor γ in Mouse Fibroblasts Results in Increased Susceptibility to Bleomycin-Induced Skin Fibrosis
Mohit Kapoor et al.
ARTHRITIS AND RHEUMATISM (2009)
Regulation of epithelial-mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing
Han Chung Chong et al.
JOURNAL OF CELL BIOLOGY (2009)
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness
Elena Campione et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2009)
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Anthony J. Trimboli et al.
NATURE (2009)
Antioxidant defense capacity in scieroderma patients
Roxana Sfrent-Cornateanu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
PPAR delta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor
Malgorzata Romanowska et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited
Armando Gabrielli et al.
SEMINARS IN IMMUNOPATHOLOGY (2008)
In perspective: Murine models of scleroderma
Minghua Wu et al.
Current Rheumatology Reports (2008)
The nuclear hormone receptor peroxisome proliferator-activated receptor β/δ potentiates cell chemotactism, polarization, and migration
Nguan Soon Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes
Michael Schuler et al.
CELL METABOLISM (2006)
First case series on the use of imiquimod for morphoea
M Dytoc et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Localized scleroderma is an autoimmune disorder
K Takehara et al.
RHEUMATOLOGY (2005)
Critical roles of the nuclear receptor PPARβ (peroxisome-proliferator-activated receptor β) in skin wound healing
NS Tan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Antinucleosome antibody is a major autoantibody in localized scleroderma
S Sato et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Essential role of Smad3 in the inhibition of inflammation-induced PPARβ/δ expression
NS Tan et al.
EMBO JOURNAL (2004)
Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway
N Di-Poï et al.
MOLECULAR CELL (2002)
Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: Cutaneous cytokines, chemokines, and immune cell activation
Y Zhang et al.
JOURNAL OF IMMUNOLOGY (2002)
Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
Y Barak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Critical roles of PPARβ/δ in keratinocyte response to inflammation
NS Tan et al.
GENES & DEVELOPMENT (2001)
Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice
L Michalik et al.
JOURNAL OF CELL BIOLOGY (2001)
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ)
JM Peters et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
